in

FDA Set to Clear Third Covid Shot for Immunocompromised

bloomberg-businessweek-01
To listen to this podcast episode, click on the Play button in the bar at the bottom of the screen. To listen while browsing, click on the Expand button at the bottom right to launch the player in a new browser tab/window.

Dr. Chris Beyrer, Professor in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA’s plan to clear a third dose of Covid vaccines for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Technology Reporter Drake Bennett explain that as incentives fail to entice people to get vaccinated, businesses are now looking to employee mandates. Bloomberg Opinion Columnist Tara Lachapelle breaks down why even Disney profits are not safe from the delta variant. And we Drive to the Close with Mace McCain, Chief Investment Officer at Frost Investment Advisors.

Host: Carol Massar. Producer: Paul Brennan.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

cato-daily-01

Military Affiliation in the Attack on the Capitol

steve-deace-01

Coming Full Circle | Guest: Corey DeAngelis | 8/12/21